2020
DOI: 10.3389/fimmu.2020.00631
|View full text |Cite
|
Sign up to set email alerts
|

Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
77
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 87 publications
(80 citation statements)
references
References 191 publications
1
77
0
2
Order By: Relevance
“…The tissue level of adenosine triphosphate (ATP) is a long-established marker of graft viability and functionality and is universal for all solid organ transplants (22). ATP is also a marker of the viability of machine-perfusion treated grafts (23). The Branchereau study highlighted that the tissuebiopsies of the pancreases in the HMP-group had a higher concentration of ATP levels when compared to the control group (21,24).…”
Section: The Rationale Of Organ Preservation By Machine Perfusionmentioning
confidence: 99%
“…The tissue level of adenosine triphosphate (ATP) is a long-established marker of graft viability and functionality and is universal for all solid organ transplants (22). ATP is also a marker of the viability of machine-perfusion treated grafts (23). The Branchereau study highlighted that the tissuebiopsies of the pancreases in the HMP-group had a higher concentration of ATP levels when compared to the control group (21,24).…”
Section: The Rationale Of Organ Preservation By Machine Perfusionmentioning
confidence: 99%
“…This suggests significant change in graft metabolism during machine perfusion. It is currently unknown if modulations such as cold or warm perfusion can revert this metabolic reprogramming or whether this can improve a posttransplantation outcome 67 …”
Section: Discussionmentioning
confidence: 99%
“…It is currently unknown if modulations such as cold or warm perfusion can revert this metabolic reprogramming or whether this can improve a posttransplantation outcome. 67 This approach has several limitations. The Langendorff set-up does not replicate fully optimal physiological conditions when compared with more challenging models, such as the working heart model.…”
Section: Discussionmentioning
confidence: 99%
“…The results achieved with this 'new' technology are encouraging. 12 The use of this device is limited for several reasons: cost, required medical staff, etc. A simpler solution might be to add an oxygen carrier to SCS.…”
Section: Coagulation In Cirrhosis Is a Complex Issue Where The Classical Tests (International Normalized Ratio [Inr] Activated Partial Thmentioning
confidence: 99%